It is our great pleasure to announce that the fourth meeting of Asian Cellular Therapy Organization (ACTO) has been scheduled from July 18th to 20th, 2013, at the National Health Research Institue (NHRI), Zhu-Nan, Taiwan.
The main purpose of this meeting is for researchers, clinicians, business persons and regulators to share knowledge and expertise regarding the development of equipment and treatments in the field of cellular therapy, i.e. hematopoietic stem cell transplantation, immunotherapy, regenerative medicine and gene therapy.
In most Asian countries, expertise in innovative cellular therapy and the development of equipment for clinical use have not been well explored. Additionally, regulatory guidelines for approval processes have not yet been firmly established, although these are essential for the development of new ideas for clinical application. These are serious obstacles for the development of our own research seeds. In this meeting, we expect to have an active discussion in a rather informal atmosphere, and will cover a variety of topics regarding cellular therapy. We believe that this meeting will help enhance communications between Asian researchers and regulators.
Your participation will be critical to make this meeting successful. We look forward to an exciting event and to seeing you in Zhu-Nan, Taiwan!
Yao-Chang, Chen M.D.
President of ACTO2013
Professor, Department of Laboratory Medicine
National Taiwan University Hospital
The 4th Meeting Information Site (http://www.acto2013.org)